Correlation Between Jagsonpal Pharmaceuticals and Tata Consultancy

Can any of the company-specific risk be diversified away by investing in both Jagsonpal Pharmaceuticals and Tata Consultancy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jagsonpal Pharmaceuticals and Tata Consultancy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jagsonpal Pharmaceuticals Limited and Tata Consultancy Services, you can compare the effects of market volatilities on Jagsonpal Pharmaceuticals and Tata Consultancy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jagsonpal Pharmaceuticals with a short position of Tata Consultancy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jagsonpal Pharmaceuticals and Tata Consultancy.

Diversification Opportunities for Jagsonpal Pharmaceuticals and Tata Consultancy

0.43

Correlation Coefficient

Jagsonpal Pharmaceuticals  Tata Consultancy

Very weak diversification

The 3 months correlation between Jagsonpal and Tata is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Jagsonpal Pharmaceuticals Limi and Tata Consultancy Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tata Consultancy Services and Jagsonpal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jagsonpal Pharmaceuticals Limited are associated (or correlated) with Tata Consultancy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tata Consultancy Services has no effect on the direction of Jagsonpal Pharmaceuticals i.e., Jagsonpal Pharmaceuticals and Tata Consultancy go up and down completely randomly.

Pair Corralation between Jagsonpal Pharmaceuticals and Tata Consultancy

Assuming the 90 days trading horizon Jagsonpal Pharmaceuticals Limited is expected to generate 2.72 times more return on investment than Tata Consultancy. However, Jagsonpal Pharmaceuticals is 2.72 times more volatile than Tata Consultancy Services. It trades about 0.16 of its potential returns per unit of risk. Tata Consultancy Services is currently generating about 0.04 per unit of risk. If you would invest  33,400  in Jagsonpal Pharmaceuticals Limited on September 27, 2024 and sell it today you would earn a total of  30,265  from holding Jagsonpal Pharmaceuticals Limited or generate 90.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Jagsonpal Pharmaceuticals Limi  vs.  Tata Consultancy Services

Jagsonpal Pharmaceuticals

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Jagsonpal Pharmaceuticals Limited are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Jagsonpal Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Tata Consultancy Services

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tata Consultancy Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Jagsonpal Pharmaceuticals and Tata Consultancy

The main advantage of trading using opposite Jagsonpal Pharmaceuticals and Tata Consultancy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jagsonpal Pharmaceuticals position performs unexpectedly, Tata Consultancy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tata Consultancy will offset losses from the drop in Tata Consultancy's long position.

The idea behind Jagsonpal Pharmaceuticals Limited and Tata Consultancy Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.